Swiggy, a well-known platform for food delivery and quick commerce, has launched a new app called Pyng. This new platform marks Swiggy’s entry into the professional services space, aiming to help people in Indian cities find reliable and skilled experts easily. According to Swiggy, Pyng is designed to solve a major problem faced by many […]
The Trump administration has put a hold on over $2.2 billion in grants and contracts given to Harvard University, as the institution refused to follow recent demands made by the US government regarding campus rules and governance. In a letter sent to Harvard, the administration demanded big changes, such as bringing in “merit-based” admission and
SEBI Chairman Tuhin Kanta Pandey has assured that Indian stock markets are stable and well-protected, even as global markets face ups and downs. Just a month into his new role, he shared his plans to build a more transparent and technology-friendly market environment. Pandey said SEBI’s main goals are investor protection, market development, and proper
SEBI Chief assures investors: Indian stock market is stable, safe and growing strongly Read More »
Former US President Donald Trump has said that there could be a few exceptions to his new 10% base tariff on most US trading partners. This comment was made while speaking to the media on his way to Florida. However, he also added that 10% would remain the minimum tariff for most countries looking to
Global market uncertainty grows as Trump hints at exceptions to 10% tariff rule Read More »
VIP Clothing shares saw a sharp rise on April 11 after the company revealed a new partnership with Zepto to expand its reach in the fast-growing quick commerce segment. The stock jumped more than 11% in intraday trading as investors reacted positively to this strategic move. Through this deal, VIP Clothing’s popular brands like Frenchie,
Biocon shares are likely to be in focus on April 11 after its subsidiary, Biocon Biologics, received USFDA approval for its cancer treatment drug Jobevne. The medicine is a biosimilar version of Bevacizumab, which is used in cancer therapy. This is seen as a positive step for the company’s business in the US market. Jobevne
Biocon share price may react as USFDA clears cancer biosimilar Jobevne for US market Read More »
The Reserve Bank of India (RBI) has revised India’s GDP growth forecast for the financial year 2025-26 to 6.5%, down from the earlier estimate of 6.7%. RBI Governor Sanjay Malhotra made the announcement on April 9, during the central bank’s Monetary Policy Committee (MPC) meeting. This decision comes alongside a 25 basis points cut in
RBI lowers India’s GDP forecast for FY26 to 6.5% amid global trade tensions and rate cut Read More »
On April 9, rate-sensitive stocks like banks, NBFCs, and auto companies did better than the broader market, after the Reserve Bank of India (RBI) reduced the repo rate by 25 basis points. The new repo rate is now 6.25%, down from 6.5% earlier. Along with this cut, the RBI also changed its policy stance to
Banking, NBFC and auto stocks perform better as RBI cuts repo rate and turns supportive Read More »
US President Donald Trump has said that his government is planning a big tariff on imported medicines. This move is to push pharma companies to make their products inside America instead of depending on countries like China and India. Speaking at a political event, Trump said that a “major” tariff is coming soon. He did
Trump to impose major import tariff on medicines, could impact Indian pharma exports Read More »
boAt’s parent company, Imagine Marketing Ltd, has filed draft documents with SEBI for a public listing worth Rs 2,000 crore. The filing has been made through the confidential pre-filing route, which keeps IPO details private in the early stage. This is the company’s second time planning to go public. In 2022, it had filed for
boAt parent Imagine Marketing secretly files draft papers for Rs 2,000 crore IPO Read More »
